FHD-609 is a PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9). FHD-609 targets to ncBAF, can be used for research of wide range of cancers that contain a mutation in a BAF complex subunit. FHD-609 in combination with Telomelysin or INO5401, may play a role in adrenocortical carcinoma (ACC) treatment. (Blue: BRD9 ligand-6 (HY-49393), Black: linker (HY-168309), Pink: (S)-Deoxy-thalidomide-Br (HY-168308) )[1][2][3][4][5].
Molecular Weight:
829.00
Purity:
99.15
CAS Number:
[2676211-64-4]
Formula:
C47H56N8O6
Target:
Epigenetic Reader Domain,PROTACs
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted